Mon, Jul 27, 8:58 AM, Zacks
Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog
Biogen's (BIIB) shares lost more than 20% on issues regarding its oral MS treatment as well as disappointing pipeline updates.
Mon, Jul 27, 8:10 AM, Zacks
Stock Market News for July 27, 2015 - Market News
Declines in biotech and commodity related stocks dragged benchmarks down to on the red on Friday